Insider trading

Period: 120 months Stock: TCRT + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

27 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

27 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

27 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

27 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
27 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
27 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

27 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
31 Dec 2024
Vieser Jaime Director
Sold at will 2×
$6.02K 3,000 at 2.01
10.4%
Not planned
1 Sep 2023
Boyle Kevin S. Sr. Chief Executive Officer
Sold on a plan
$9.54K 68,014 at 0.14
7.9%
Planned (10b5-1)
29 Nov 2022
Vieser Jaime Director · indirect
Bought
$812.50K 1,250,000 at 0.65
opened
Largest buy in 3 yrs
29 Nov 2022
Postma Robert W Director · indirect
Bought
$487.50K 750,000 at 0.65
17.6%
Largest buy in 3 yrs
22 Dec 2021
De Groot Eleanor EVP, Operations
Sold, plan not stated
$25.57K 20,132 at 1.27
7.8%
17 Nov 2021
Boyle Kevin S. Sr. Chief Executive Officer
Bought
$12.76K 9,116 at 1.40
1.0%
Largest buy in 3 yrs
16 Nov 2021
Boyle Kevin S. Sr. Chief Executive Officer
Bought
$1.24K 884 at 1.40
0.1%
First buy on file
29 Sep 2021
Vieser Jaime Director
Bought
$191.00K 100,000 at 1.91
16.5%
First buy on file
2 Sep 2021
Postma Robert W Director · indirect
Bought
$94.27K 54,492 at 1.73
1.3%
First buy on file
2 Sep 2021
Hagen Heidi Director
Bought
$41.84K 23,770 at 1.76
19.5%
First buy on file
2 Sep 2021
Postma Robert W Director
Bought
$35.48K 20,508 at 1.73
1.7%
First buy on file
1 Sep 2021
Huang James Director
Bought
$171.00K 100,000 at 1.71
×12
First buy on file
1 Sep 2021
Weis Holger Director
Bought
$91.50K 50,000 at 1.83
71.3%
First buy on file
8 Jan 2021
Buck Jill EVP, GM Gene Therapy
Sold, plan not stated
$87.03K 27,894 at 3.12
12.3%
8 Jan 2021
Hadfield Robert General Counsel and Secretary
Sold, plan not stated
$82.68K 26,500 at 3.12
16.6%
8 Jan 2021
Lafond Kevin G SVP, Treasurer & CAO
Sold, plan not stated
$55.68K 18,020 at 3.09
22.0%
4 Jan 2021
Cooper Laurence James Neil President and CEO
Sold, plan not stated
$286.43K 105,693 at 2.71
5.5%
4 Jan 2021
De Groot Eleanor EVP, GM Cell Therapy
Sold, plan not stated
$58.81K 21,620 at 2.72
9.5%
2 Jan 2020
Buck Jill EVP, GM Gene Therapy
Sold, plan not stated
$127.05K 27,923 at 4.55
13.8%
2 Jan 2020
De Groot Eleanor EVP, GM Cell Therapy
Sold, plan not stated
$113.25K 24,890 at 4.55
12.5%
2 Jan 2020
MAUNEY DAVID M MD President
Sold, plan not stated
$101.89K 22,394 at 4.55
10.3%
2 Jan 2020
Lafond Kevin G SVP, Treasurer & CAO
Sold, plan not stated
$98.14K 21,570 at 4.55
25.2%
2 Jan 2020
Hadfield Robert General Counsel and Secretary
Sold, plan not stated
$76.68K 16,853 at 4.55
14.3%
30 Dec 2019
Cooper Laurence James Neil Chief Executive Officer
Sold, plan not stated
$540.19K 110,694 at 4.88
6.0%
26 Nov 2019
Lafond Kevin G SVP, Treasurer & CAO
Sold, plan not stated
$61.25K 11,667 at 5.25
12.0%
8 Nov 2017
Cooper Laurence James Neil Chief Executive Officer
Bought
$30.14K 6,440 at 4.68
0.6%
First buy on file
8 Nov 2017
MAUNEY DAVID M MD EVP and Chief Business Officer
Bought
$19.98K 4,270 at 4.68
7.9%
First buy on file
Showing 1–27 of 27.